Kardigan KARD
NASDAQ KARD
$13.82 -0.30 (-2.12%)
At close: Nov 13, 2026 · 4:00 PM EST

Kardigan (KARD) Cash from Financing Activities (2025 - 2026)

Updated

Kardigan (KARD) reported Cash from Financing Activities of -$3.4 million for Q3 2026, compared with $242.91 million a year earlier.

Analysis

Kardigan (KARD) Cash from Financing Activities (2025 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Kardigan's Cash from Financing Activities came in at $538.55 million; for FY2025, it came in at $447.81 million, up 326.4% from FY2024.

  • By year, Cash from Financing Activities came in at $105.01 million in FY2024.
  • Per Business Quant data, the three quarters before Q3 2026 came in at $426.91 million (Q2 2026), $10.32 million (Q1 2026) and $104.71 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -7.22 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -8.53 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 6.82 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -2.43 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 6.63 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -4.39 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -1.53 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -2.51 Bn
10 Kardigan 1.29 Bn -398.44 Mn - -3.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -3.40 Mn
Jun 30, 2026 426.91 Mn
Mar 31, 2026 10.32 Mn
Jun 30, 2025 184,000.00
Mar 31, 2025 100.00 Mn
API Access

Kardigan Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=KARD&period=max&api_key=YOUR_API_KEY